• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃内酸度24小时监测:兰索拉唑30毫克与泮托拉唑40毫克的比较

Twenty-four-hour monitoring of intragastric acidity: comparison between lansoprazole 30mg and pantoprazole 40mg.

作者信息

Florent C, Forestier S

机构信息

Digestive Pathology Department, Hopital Saint-Antoine, Paris, France.

出版信息

Eur J Gastroenterol Hepatol. 1997 Feb;9(2):195-200. doi: 10.1097/00042737-199702000-00017.

DOI:10.1097/00042737-199702000-00017
PMID:9058634
Abstract

OBJECTIVE

To date, there is no published study, comparing the effects of lansoprazole and pantoprazole on gastric acid secretion inhibition. The aim of this study, was to compare the effects of these two drugs on 24-h intragastric pH-metry.

DESIGN

Twelve healthy volunteers were included in an open, randomized, crossover study. Each subject received lansoprazole 30mg during 7 days followed, after a 14-day wash-out period, by pantoprazole 40 mg for 7 days or vice versa. Intragastric 24-h pH monitoring was performed before the treatment, and then after the first and seventh intake in each treatment period.

RESULTS

The decrease in gastric acidity on daytime, night-time and total 24-h periods during both treatments was significantly different from the base value. Significant differences in acid inhibition were found between lansoprazole 30mg and pantoprazole 40 mg during daytime and 24 h after the first intake. After repeated dose regimens, a significant difference was detected between treatment periods but only for pH above 4. After the first dose, the median pH value with lansoprazole was also significantly greater than for pantoprazole. Pantoprazole activity increased significantly from first to seventh intake, in contrast to lansoprazole.

CONCLUSION

Lansoprazole 30 mg was significantly more potent than pantoprazole 40 mg on 24-h pH profiles on the first and seventh days. The antisecretory effect of lansoprazole was maximum after the first intake whereas pantoprazole activity increased significantly between the first and last intake.

摘要

目的

迄今为止,尚无已发表的研究比较兰索拉唑和泮托拉唑对胃酸分泌抑制的作用。本研究的目的是比较这两种药物对24小时胃内pH值测定的影响。

设计

12名健康志愿者纳入一项开放、随机、交叉研究。每名受试者先接受7天30毫克兰索拉唑治疗,在14天洗脱期后,再接受7天40毫克泮托拉唑治疗,或反之。在治疗前、各治疗期首次服药后和第七次服药后进行24小时胃内pH监测。

结果

两种治疗期间白天、夜间和24小时总体胃酸度的降低与基线值相比有显著差异。首次服药后白天和24小时期间,30毫克兰索拉唑和40毫克泮托拉唑之间的抑酸作用有显著差异。重复给药方案后,治疗期之间存在显著差异,但仅针对pH值高于4的情况。首次服药后,兰索拉唑的中位pH值也显著高于泮托拉唑。与兰索拉唑不同,泮托拉唑的活性从首次服药到第七次服药显著增加。

结论

在第一天和第七天的24小时pH值曲线上,30毫克兰索拉唑比40毫克泮托拉唑的效力显著更强。兰索拉唑的抑分泌作用在首次服药后最大,而泮托拉唑的活性在首次服药和末次服药之间显著增加。

相似文献

1
Twenty-four-hour monitoring of intragastric acidity: comparison between lansoprazole 30mg and pantoprazole 40mg.胃内酸度24小时监测:兰索拉唑30毫克与泮托拉唑40毫克的比较
Eur J Gastroenterol Hepatol. 1997 Feb;9(2):195-200. doi: 10.1097/00042737-199702000-00017.
2
Acid suppression in healthy subjects following lansoprazole or pantoprazole.兰索拉唑或泮托拉唑对健康受试者的胃酸抑制作用。
Aliment Pharmacol Ther. 2002 Mar;16(3):425-33. doi: 10.1046/j.1365-2036.2002.01168.x.
3
Twenty-four-hour intragastric pH profiles and pharmacokinetics following single and repeated oral administration of the proton pump inhibitor pantoprazole in comparison to omeprazole.与奥美拉唑相比,单次及重复口服质子泵抑制剂泮托拉唑后的24小时胃内pH值曲线及药代动力学。
Aliment Pharmacol Ther. 1996 Jun;10(3):359-66. doi: 10.1111/j.0953-0673.1996.00359.x.
4
Effects on 24-hour intragastric pH: a comparison of lansoprazole administered nasogastrically in apple juice and pantoprazole administered intravenously.对24小时胃内pH值的影响:比较经鼻胃管给予苹果汁中兰索拉唑与静脉给予泮托拉唑的效果。
Am J Gastroenterol. 2001 Jul;96(7):2058-65. doi: 10.1111/j.1572-0241.2001.03939.x.
5
A comparison of simplified lansoprazole suspension administered nasogastrically and pantoprazole administered intravenously: effects on 24-h intragastric pH.经鼻胃管给予简化兰索拉唑混悬液与静脉给予泮托拉唑的比较:对24小时胃内pH值的影响
Aliment Pharmacol Ther. 2001 Nov;15(11):1807-17. doi: 10.1046/j.1365-2036.2001.01098.x.
6
Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors.给药第一天的酸抑制作用:四种质子泵抑制剂的比较
Aliment Pharmacol Ther. 2003 Jun 15;17(12):1507-14. doi: 10.1046/j.1365-2036.2003.01496.x.
7
Dose-dependent control of intragastric pH by pantoprazole, 10, 20 or 40 mg, in healthy volunteers.泮托拉唑10毫克、20毫克或40毫克对健康志愿者胃内pH值的剂量依赖性控制。
Aliment Pharmacol Ther. 2002 Apr;16(4):829-36. doi: 10.1046/j.1365-2036.2002.01232.x.
8
Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms.在患有胃食管反流症状的患者中,40毫克埃索美拉唑比30毫克兰索拉唑、20毫克奥美拉唑、40毫克泮托拉唑和20毫克雷贝拉唑能更有效地控制胃内酸度。
Eur J Clin Pharmacol. 2004 Oct;60(8):531-9. doi: 10.1007/s00228-004-0804-6. Epub 2004 Sep 2.
9
Effects of rabeprazole, lansoprazole and omeprazole on intragastric pH in CYP2C19 extensive metabolizers.雷贝拉唑、兰索拉唑和奥美拉唑对CYP2C19广泛代谢者胃内pH值的影响。
Aliment Pharmacol Ther. 2002 Oct;16(10):1811-7. doi: 10.1046/j.1365-2036.2002.01348.x.
10
The acidity index: a simple approach to the measurement of gastric acidity.酸度指数:一种测量胃酸度的简单方法。
Aliment Pharmacol Ther. 2004 Feb 15;19(4):443-8. doi: 10.1111/j.1365-2036.2004.01853.x.

引用本文的文献

1
Interchangeable Use of Proton Pump Inhibitors Based on Relative Potency.基于相对效力的质子泵抑制剂的可互换使用。
Clin Gastroenterol Hepatol. 2018 Jun;16(6):800-808.e7. doi: 10.1016/j.cgh.2017.09.033. Epub 2017 Sep 28.
2
Inhibitory effects of intravenous lansoprazole 30 mg and pantoprazole 40 mg twice daily on intragastric acidity in healthy Chinese volunteers: a randomized, open-labeled, two-way crossover study.兰索拉唑 30mg 静脉注射和泮托拉唑 40mg 每日两次对健康中国志愿者胃内酸度的抑制作用:一项随机、开放、两交叉研究。
Med Sci Monit. 2012 Feb;18(2):CR125-130. doi: 10.12659/msm.882468.
3
Relative potency of proton-pump inhibitors-comparison of effects on intragastric pH.
质子泵抑制剂的相对效价——对胃内pH值影响的比较
Eur J Clin Pharmacol. 2009 Jan;65(1):19-31. doi: 10.1007/s00228-008-0576-5. Epub 2008 Oct 17.
4
What is potent acid inhibition, and how can it be achieved?什么是强效酸抑制,如何实现强效酸抑制?
Drugs. 2005;65 Suppl 1:13-23. doi: 10.2165/00003495-200565001-00004.
5
The role of proton pump inhibitors in gastro-oesophageal reflux disease.质子泵抑制剂在胃食管反流病中的作用。
Drugs. 2004;64(3):277-95. doi: 10.2165/00003495-200464030-00004.
6
Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.泮托拉唑:其药理特性及在酸相关性疾病管理中的治疗应用的最新进展。
Drugs. 2003;63(1):101-33. doi: 10.2165/00003495-200363010-00006.
7
Formulary management of proton pump inhibitors.质子泵抑制剂的处方集管理
Pharmacoeconomics. 1999 Sep;16(3):225-46. doi: 10.2165/00019053-199916030-00002.
8
Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders.质子泵抑制剂。用于胃肠道疾病的药理学及应用原理。
Drugs. 1998 Sep;56(3):307-35. doi: 10.2165/00003495-199856030-00002.
9
Lansoprazole. An update of its pharmacological properties and clinical efficacy in the management of acid-related disorders.兰索拉唑。其治疗酸相关性疾病的药理特性及临床疗效的最新进展。
Drugs. 1997 Sep;54(3):473-500. doi: 10.2165/00003495-199754030-00010.